All three, Efavirenz, Emtricitabine, and Tenofovir are each approved for the treatment of HIV. In addition Efavirenz and Emtricitabine are approved for use in children who are infected with HIV. These three medicines are frequently prescribed together, the manufacturers have combined them into one tablet. Atripla was approved for use by the FDA as a combination tablet in July 2006, for the treatment of HIV in adults. Atripla may be used as a complete regimen or in combination with other anti retroviral.
As a result Atripla has become a leading medication in the fight against HIV/AIDS and has helped people living with HIV a great deal. This helps to make dealing with HIV simplier and the drug regimens more effective because it reduces forgotten doses. This helps to reduce the amount of drug resistant mutations that occur due to misdoses.
Atripla does not cure or prevent HIV infection or HIV/AIDS and does not reduce the risk of passing the virus to other people. There are a number of side effects associated with the use of Atripla. Serious side effects of efavirenz include abnormal thinking, confusion, depression, hallucinations, memory loss, paranoid thinking, and thoughts of suicide. Some patients can develop a severe rash. NRTIs in Atripla can sometimes cause a fatal lactic acidosis and disease of liver as well as blood problems or muscle weakness. Notify your doctor if you begin to experience pain in your joints, or muscles and weakness, trouble breathing, pain in your stomach with nausea or vomiting, feeling cold, irregular heartbeat, dizziness, jaundice, dark urine or loss of appetite. Patients should notify their doctor if they have any of the side effects listed. Some side effects may not be serious and may lessen or disappear with continued use of the medicine. Individuals should tell a doctor if these side effects continue or are bothersome. Stopping Atripla may cause a severe reaction in patients who are also infected with hepatitis B.
0 Responses to “Tenovir/Emtricitabine/Efavirenz (Atripla)”